Tocotrienols complex - palm: Proposed revision of draft compositional guideline
18 April 2013
This consultation closed on 19 December 2012. Submissions received and TGA's responses are now available.
Please note that a further revision is open for an additional round of consultation.
At the request of industry, the TGA revised a number of parameters included in the draft compositional guideline for tocotrienols complex - palm and sought comments on the proposed revision of the draft guideline from stakeholders.
A number of the method references and acceptance criteria have been revised and these proposed changes are presented together with the current specifications.
Proposed revision of draft compositional guideline for tocotrienols complex - palm
Print version
Proposed revision of draft compositional guideline for tocotrienols complex - palm (pdf,214kb)
Name of the ingredient
Tocotrienols complex - palm (AAN)
Definition of the ingredient
Tocotrienols complex - palm is a mixture of tocotrienols and α-tocopherol derived from the oil of the palm fruit, Elaeis guinensis. The manufacturing process involves alcoholic trans-esterification of crude palm oil followed by distillation.
Table 1: Ingredient specific requirements
| Test | Method reference | Acceptance criteria |
|---|---|---|
| Description | ||
| Appearance | Visual |
Current: None Proposed: Amber coloured oily liquid |
| Characteristics | ||
| Specific gravity | USP<841> |
Current: 0.956 Proposed: 0.94-0.97 |
| Moisture | USP<921> |
Current: Not more than 1% Proposed: Not more than 1% |
| Identification | ||
| Tocotrienols complex - palm | HPLC |
Current: None Proposed: Complies with the chromatogram for the authenticated reference materials |
| Assay | ||
| Phyto-tocotrienols complex | HPLC |
Current: Not less than 50% Proposed: 30–50%1 |
| Alpha-tocopherol | HPLC |
Current: 10–14% Proposed: 6–18% |
| Alpha-tocotrienol | HPLC |
Current: 10–14% Proposed: 6–17% |
| Beta-tocotrienol | HPLC |
Current: None Proposed: 0.3–2.0% |
| Gamma-tocotrienol | HPLC |
Current: 20–24% Proposed: 6–24% |
| Delta-tocotrienol | HPLC |
Current: 5–7% Proposed: 1–9% |
| Monoglycerides/diglycerides/ triglycerides |
GC |
Current: 34.5% Proposed: 10–70% |
| Phytosterol complex | GC |
Current: 4.0% Proposed: 3–12% |
| Palm squalene | GC |
Current: 8–12% Proposed: 2–15% |
Notes
- The sum of alpha-tocopherol, alpha-tocotrienol, beta-tocotrienol, gamma-tocotrienol and delta-tocotrienol.
Table 2: Incidental constituents
| Test | Method reference | Acceptance criteria |
|---|---|---|
| Residual solvents | ||
| Residual solvents | Ph Eur method 2.4.24 |
Current: None Proposed: Complies |
| Incidental metals and non-metals | ||
| Heavy metals (as lead) | BP (Appendix VII) |
Current: Not more than 20 ppm Proposed: Not more than 20 ppm |
| Pesticide residues and environmental contaminants (including agricultural and veterinary substances) | ||
| Pesticide residues | Ph Eur method 2.8.13 |
Current: None Proposed: Complies |
| Other organic or inorganic impurities or toxins | ||
| Peroxide value | BP (Appendix X F) |
Current: Not more than 5 Proposed: Not more than 5 |
| Microbiology | ||
| While substance manufacturers are encouraged to include limits for objectionable microorganisms, it is the product into which those substances are formulated that is subject to a legally binding set of criteria. The Therapeutic Goods Order No. 77 'Microbiological Standards for Medicines' mandates that any finished product that contains the ingredient, alone or in combination with other ingredients, must comply with the microbial acceptance criteria set by Clause 9 of the Order. | ||
Key to abbreviations
BP: British Pharmacopoeia
GC: Gas chromatography
HPLC: High-pressure liquid chromatography
Ph Eur: European Pharmacopoeia
USP: United States Pharmacopoeia
Content last updated: Thursday, 18 April 2013
Content last reviewed: Thursday, 18 April 2013
Web page last updated: Friday, 19 April 2013
URL: http://www.tga.gov.au/newsroom/consult-cm-cg-draft-tocotrienols-complex-palm-121107.htm
